Companion Diagnostics Guidance Finalized, But LDT Context Will Be Key
This article was originally published in The Gray Sheet
Executive Summary
FDA has finalized its guidance on companion diagnostics with very few revisions from the draft it released three years ago. But the final guidance was released simultaneously with FDA’s much-delayed proposal to begin actively regulating lab-developed tests, which presents important underlying questions for companion diagnostic policy.